#eu 2017

http://www.who.int/medicines/publications/druginformation/issues/77_INN_Recommended_List.pdfActive Substance General information The active substance in Oxervate, cenegermin, is a recombinant human Nerve Growth factor (rhNGF) produced in E. coli strain HMS174. The molecule is identical to human Nerve Growth factor (NGF), a naturally occurring human protein. In humans, NGF is naturally produced as…

ヌシネルセンナトリウム Nusinersen Sodium C234H323N61Na17O128P17S17 : 7500.89 [1258984-36-9 , ヌシネルセン] Nusinersen sodium C234H323N61O128P17S17.17Na, 7500.8854 UNII 4CHB7QQU1Q ISIS 396443 Nusinersen sodium was approved by the US Food and Drug Administration (FDA) on Dec 23, 2016, and approved by the European Medicines Agency’s (EMA) on May 30, 2017, and approved by Pharmaceuticals and Medical Devices Agency of…

PADELIPORFIN 759457-82-4; 457P824, RN: 759457-82-4 UNII: EEO29FZT86 3-[(2S,3S,12R,13R)-8-acetyl-13-ethyl-20-(2-methoxy-2-oxoethyl)-3,7,12,17-tetramethyl-18-(2-sulfoethylcarbamoyl)-2,3,12,13-tetrahydroporphyrin-22,24-diid-2-yl]propanoic acid;palladium(2+)…